FGFR3 and Miyoshi myopathy: Studies have shown that the use of immunohistochemistry (IHC) to detect the expression of cancer-related genes, such as fibroblast growth factor receptor 3 (FGFR3), the tumor suppressor gene p53, and transcription factor c-maf can be an alternative method for the prognostic analysis of MM [14–17].